Page last updated: 2024-08-24

meglumine antimoniate and Multiple Organ Failure

meglumine antimoniate has been researched along with Multiple Organ Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortes, C; Cuestas, D; Forero, Y; Galvis, I; Mora, S; Motta, A; Peñaranda, E; Pérez, C; Puentes, J; Velasquez, O1
Blanquer, J; Llombart, A; Mesejo, A; Núñez, C; Pérez, PL; Ruiz, F; Simó, M1

Reviews

1 review(s) available for meglumine antimoniate and Multiple Organ Failure

ArticleYear
Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): one more reason for a new effective treatment against leishmaniasis.
    International journal of dermatology, 2018, Volume: 57, Issue:11

    Topics: Antiprotozoal Agents; Drug Hypersensitivity Syndrome; Humans; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Multiple Organ Failure

2018

Other Studies

1 other study(ies) available for meglumine antimoniate and Multiple Organ Failure

ArticleYear
[Visceral leishmaniasis and multiple organ failure].
    Enfermedades infecciosas y microbiologia clinica, 1993, Volume: 11, Issue:10

    Topics: Adolescent; Animals; Bone Marrow; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Multiple Organ Failure; Organometallic Compounds

1993